The Limitations of Rilutek

As most people with amyotrophic lateral sclerosis (ALS) know, Rilutek is the only prescription medication that prolongs life. Unfortunately, this increase is only about two months. Some people may enjoy greater benefits, especially those with bulbar-onset ALS, but most people will experience far less than a year of additional life with riluzole (Rilutek). Unfortunately, not every patient is likely to experience any benefit from treatment with riluzole. The drug is not likely to be of benefit to anyone with a tracheostomy, for example. Therefore, it is reasonable and common for people with ALS (PALS) to look for alternatives to Rilutek, or at least medications that can be used in addition to this prescription drug. Continue reading Alternatives to Rilutek →